Skip to main content
Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.562
-0.041 (-6.78%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Barinthus Biotherapeutics Revenue

In the year 2024, Barinthus Biotherapeutics had annual revenue of $14.97M with 1,766.46% growth.

Revenue (ttm)
$14.97M
Revenue Growth
+1,766.46%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
105
Market Cap
22.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202414.97M14.17M1,766.46%
Dec 31, 2023802.00K-43.90M-98.21%
Dec 31, 202244.70M44.44M16,580.22%
Dec 31, 2021268.00K-4.55M-94.44%
Dec 31, 20204.82M-2.02M-29.57%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neuphoria Therapeutics 14.99M
Evaxion 7.53M
Marker Therapeutics 4.69M
Vistagen Therapeutics 789.00K
Exicure 500.00K
Hyperion DeFi 345.32K
Revenue Rankings

BRNS News

More News